A nurse, and then, within minutes, an on-call pediatrician, arrived to check on Nora, drawn by Renee’s screaming and the general chaos that had erupted in the room.
Dr. Amara Voss, the pediatrician, examined the birthmark carefully, gently turning Nora to get a full view of it under better light, her expression professional and calm in a way that felt, honestly, like the first steady thing in the room in several minutes.
“This is a congenital melanocytic nevus,” she said, once she’d finished the examination. “A birthmark present from birth, larger than average, which does place her in a higher-risk category for melanoma later in life compared to the general population. But I want to be very clear with all of you — higher risk isn’t the same as inevitable, and modern dermatological monitoring for exactly this kind of nevus is considerably more advanced than whatever care existed when your mother was managing hers decades ago.”
“How much more advanced,” Desmond asked, his voice still unsteady.
“Regular monitoring starting in infancy, typically every six months, with a pediatric dermatologist trained specifically in these cases,” Dr. Voss said. “Any changes in size, color, or texture get caught early, often years before they’d become dangerous. Some nevi like this never develop into anything at all across an entire lifetime, with proper monitoring. I understand this is frightening, given your family history. I want you to understand it’s also considerably more manageable today than it would have been for your mother’s generation.”
